Department of Intensive Care Unit, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Clinical Trial Centre, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Clin Respir J. 2023 May;17(5):447-455. doi: 10.1111/crj.13614. Epub 2023 Apr 19.
Lung is often implicated in sepsis, resulting in acute respiratory distress syndrome (ARDS). The alveolar-arterial oxygen gradient [D(A-a)O ] reflects lung diffusing capacity, which is usually compromised in ARDS. But whether D(A-a)O impacts the prognosis of patients with sepsis remains to be explored. Our study aims to investigate the association between D(A-a)O and 28-day mortality in patients with sepsis using a large sample, multicenter Medical Information Mart for Intensive Care (MIMIC)-IV database.
We extracted a data of 35 010 patients with sepsis from the retrospective cohort MIMIC-IV database, by which the independent effects of D(A-a)O on 28-day death risk was investigated, with D(A-a)O as being the exposure variable and 28-day fatality being the outcome variable. Binary logistic regression and a two-piecewise linear model were employed to explore the relationship between D(A-a)O and the 28-day death risk after confounding factors were optimized including demographic indicators, Charlson comorbidity index (CCI), Sequential Organ Failure Assessment (SOFA) score, drug administration, and vital signs.
A total of 18 933 patients were finally included in our analysis. The patients' average age was 66.67 ± 16.01 years, and the mortality at 28 days was 19.23% (3640/18933). Multivariate analysis demonstrated that each 10-mmHg rise of D(A-a)O was linked with a 3% increase in the probability of death at 28 days either in the unadjusted model or in adjustment for demographic variables (Odds ratio [OR]: 1.03, 95% CI: 1.02 to 1.03). But, each 10 mmHg increase in D(A-a)O was associated with a 3% increase of death (OR: 1.03, 95% CI: 1.023 to 1.033) in the case of adjustment for all covariants. Through smoothed curve fitting and generalized summation models, we found that non-linear relationship existed between D(A-a)O and the death at 28-day, which demonstrated that D(A-a)O had no any impacts on the prognosis of patients with sepsis when D(A-a)O was less than or equal to 300 mmHg, but once D(A-a)O exceeded 300 mmHg, however, every 10 mmHg elevation of D(A-a)O is accompanied by a 5% increase of the 28-day death (OR: 1.05; 95% CI:1.04 to 1.05, p < 0.0001).
Our findings suggests that D(A-a)O is a valuable indicator for the management of sepsis patient, and it is recommended that D(A-a)O be maintained less than 300 mmHg as far as possible during sepsis process.
肺部常受累于脓毒症,导致急性呼吸窘迫综合征(ARDS)。肺泡-动脉血氧分压差[D(A-a)O]反映了肺弥散能力,而在 ARDS 中通常会受到损害。但是 D(A-a)O 是否会影响脓毒症患者的预后仍有待探讨。我们的研究旨在使用大型多中心医学信息监护 IV (MIMIC-IV)数据库来研究 D(A-a)O 与脓毒症患者 28 天死亡率之间的关系。
我们从回顾性队列 MIMIC-IV 数据库中提取了 35010 例脓毒症患者的数据,通过将 D(A-a)O 作为暴露变量,28 天病死率作为结局变量,来研究 D(A-a)O 对 28 天死亡风险的独立影响。采用二元逻辑回归和两段线性模型来探讨在优化包括人口统计学指标、Charlson 合并症指数(CCI)、序贯器官衰竭评估(SOFA)评分、药物治疗和生命体征等混杂因素后,D(A-a)O 与 28 天死亡风险之间的关系。
最终有 18933 例患者纳入我们的分析。患者的平均年龄为 66.67±16.01 岁,28 天死亡率为 19.23%(3640/18933)。多变量分析表明,在未调整模型或调整人口统计学变量后,D(A-a)O 每升高 10mmHg,28 天死亡的概率分别增加 3%(优势比[OR]:1.03,95%置信区间:1.02 至 1.03)。但是,在调整所有协变量后,D(A-a)O 每升高 10mmHg,死亡风险增加 3%(OR:1.03,95%置信区间:1.023 至 1.033)。通过平滑曲线拟合和广义求和模型,我们发现 D(A-a)O 与 28 天病死率之间存在非线性关系,表明当 D(A-a)O 小于或等于 300mmHg 时,D(A-a)O 对脓毒症患者的预后没有任何影响,但一旦 D(A-a)O 超过 300mmHg,D(A-a)O 每升高 10mmHg,28 天病死率就会增加 5%(OR:1.05;95%置信区间:1.04 至 1.05,p<0.0001)。
我们的研究结果表明,D(A-a)O 是脓毒症患者管理的一个有价值的指标,建议在脓毒症过程中尽量将 D(A-a)O 维持在 300mmHg 以下。